These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1352211

  • 21. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids.
    Spickett CM, Jerlich A, Panasenko OM, Arnhold J, Pitt AR, Stelmaszyńska T, Schaur RJ.
    Acta Biochim Pol; 2000; 47(4):889-99. PubMed ID: 11996112
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Studies on nucleic acids in lupus vulgaris treated with isonicotinic acid hydrazine (INH)].
    KOZAKIEWICZ J.
    Przegl Dermatol; 1961; 48():301-15. PubMed ID: 13753746
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 2-hydroxy-isonicotinic acid--an intermediate in metabolism of isonicotinic acid hydrazide & isonicotinic acid by Sarcina.
    Gupta RC, Shukla OP.
    Indian J Biochem Biophys; 1978 Dec; 15(6):492-3. PubMed ID: 753753
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Isoniazid-mediated irreversible inhibition of the myeloperoxidase antimicrobial system of the human neutrophil and the effect of thyronines.
    van Zyl JM, Basson K, Uebel RA, van der Walt BJ.
    Biochem Pharmacol; 1989 Jul 15; 38(14):2363-73. PubMed ID: 2546565
    [Abstract] [Full Text] [Related]

  • 29. Myeloperoxidase-mediated activation of xenobiotics by human leukocytes.
    Hofstra AH, Uetrecht JP.
    Toxicology; 1993 Oct 05; 82(1-3):221-42. PubMed ID: 8236277
    [Abstract] [Full Text] [Related]

  • 30. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.
    Jiang X, Khursigara G, Rubin RL.
    Science; 1994 Nov 04; 266(5186):810-3. PubMed ID: 7973636
    [Abstract] [Full Text] [Related]

  • 31. Paradoxical pleural response to antituberculous chemotherapy and isoniazid-induced lupus. Review and report of two cases.
    Hiraoka K, Nagata N, Kawajiri T, Suzuki K, Kurokawa S, Kido M, Sakamoto N.
    Respiration; 1998 Nov 04; 65(2):152-5. PubMed ID: 9580929
    [Abstract] [Full Text] [Related]

  • 32. Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin.
    Meng X, Maggs JL, Usui T, Whitaker P, French NS, Naisbitt DJ, Park BK.
    Chem Res Toxicol; 2015 Jan 20; 28(1):51-8. PubMed ID: 25489718
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Mechanism of hypersensitivity reactions: proposed involvement of reactive metabolites generated by activated leukocytes.
    Uetrecht J.
    Trends Pharmacol Sci; 1989 Nov 20; 10(11):463-7. PubMed ID: 2692259
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Different oxidative pathways of isonicotinic acid hydrazide and its meta-isomer, nicotinic acid hydrazide.
    van der Walt BJ, van Zyl JM, Kriegler A.
    Int J Biochem; 1994 Sep 20; 26(9):1081-93. PubMed ID: 7988733
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.